The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yesterday was an incredible day for Trellus Health, as their share price on the LSE soared by an impressive 53.13% according to the end of day market report. These shares are highly sought after, making it challenging for me to acquire any available ones in the past week. With former Directors from Axiom and Astra Zeneca on board, the potential of this company seems boundless. I am hopeful to purchase more shares today!
Very quiet here, I've topped up on the recent downturn. Very large spread (15%!).
I stand Corrected Hawker. Silly mistake. It actually makes the RNS even better.
I really don't know what impresses the market these days. Not just Trellus but other companies I've looked at. In previous markets good news has prompted an uplift in valuation but it seems those days have temporarily gone. Trellus has two very positive RNSs and has been marked down on both occasions. I think I'll hibernate for 6 months. It would save on electricity at least.
Yes that's my read on it too, so the market opportunity should be a multiple of the 16k professionals. On top of this Trellus has the potential to open up a significant portion of the corporate employee health plan market, I very much like the point they made about the productivity drop off with sufferers of IBS, UC, IBD, etc and how this could be improved with Trellus's resilience health plan offering. However, they first need the commercial validation and success from the announced plans and channels with Mount Sinai and GI onDEMAND. Once they have this I'm sure Mount Sinai will be a significant door opener to other plans. I think Trellus has huge potential but the market won't see it until the numbers start rolling in, I get that. Happy to hold for the long term and have added more this week.
Hi Mike, maybe I've missed it, but where do you get 16,000 patients? The RNS mentions it being offered to 16,000 professionals and hence all their patients ("The Trellus IBD program will be the only resilience driven self-management training solution offered via this platform to over 16,000 gastrointestinal ("GI") professionals across the US for the benefit of the millions of patients they collectively serve."), but maybe I missed it elsewhere.
..... but I'm happy with the professionals!
Can only agree. The Market in general is carp but the behaviour with the last 2 RNSs is bizarre. The BOD must be tearing their hair out not to mention us. What have they got to do to get the SP up.
This RNS mentions 16,000 patients being dealt with in this programme and TRLS only needs 8,000 to break even.
See thats what i was puzzed by too. There has been some really positive news in the last week yet the MMs drop the share price like this. Absolute joke
So the company announces four major channels, through which they’re now starting to roll-out and commercialise their resilience health service, and the market responds like this. The market really has lost its mind! Well let’s see where the shares are once the numbers start rolling in, I for one am adding to my position today, the Trellus Health team are on a roll!
Another nice rise today :)
Pretty solid buying today. I'm surprised that the SP hasn't been jacked up more in view of this. It looks like lots of profit takers were around yesterday but fewer today. If you want to take a profit go right ahead but I'm waiting 3-6 months personally.
Sod it, I have talked myself into selling, just worried the trading looks a bit frothy now but still believe the company will be a success longer term. Will buy back in if it drops back down to 10. If not, best of luck all
Yes, I guess it was naive to think this would move up in a straight line, but even if it falls back to 10 I would expect resistance there and then it might bounce back to 14 and even beyond
Inevitable profit taking today and good luck to them but longer term this should be on an upward trajectory IMHO.
As far as I know the AIM market has less stringent criteria for listing in the way of profitability, shorter history etc but I'm no expert. Also the AIM is quite mature and fairly liquid.
TRLS is spin off from Mt Sinai and follows 2 of their other companies RENX and VRCI on to AIM so I suppose they were happy with the process. The other 2 are potential blockbusters but the Market has slaughtered their SPs, similar to what happened to TRLS. If the companies get it right they look like multi-baggers to me.
Zero for the business????
Well we're finally above cash value, I wonder if we'll see any resistance/selling from here?
Stll several bags to go here!! Were not even at the cash position yet.
Amazing day yesterday with a 53.13% share price increase for Trellus Health, aka TRLS on the LSE end of day market report!
These shares really are in sticky hands, with many seeing the long term vision of the company, as its been a battle for me the past week to scoop up any that become available.
With Directors ex Axiom and Astra Zeneca, the prospects of this company are limitless.
Hopefully I'll be able to buy more shares today!
I've been diagnosed with Crohn's since 2019 so this company is particularly interesting to me. From my brief look so far the tech looks great. Unplanned hospitalisation is a common feature for many of us with IBD. In fact, just last week I rushed to A&E after the immunosuppressants I'm on for Crohn's meant a trivial viral infection I had turned septic and was putting my body in a very dangerous position.
Anyway, my one question so far - which I understand has probably been answered 1,000 times but I can't find it - is why did this US based (biotech?) company decide to list on AIM? Seems very strange.
Not that I'm complaining, I mean the company looks great from both a product and fundamentals point of view at the moment.
How large do you think the return could be this year? Pennies to pounds type so rise? Guess it will depend on progress, only 162 mill shares in issue and pharma company’s do tend to be bought out for plenty of money so guess it’s not too inconceivable! Got to be in it to win it though so worth holding I believe from these levels. GLA
Great post DJm1
Just one point for newbies its a lot more than just a app
Well worth watching the presentation
When is the next update due? Thanks
You use 5% but even if the figure is only 1%, that's still 30,000 patients and, as you say, the B/E is 7,000. Personally, in view of the acceptance mooted by Marla, I can't believe that the figure will not be way north of 1%.
Marla the CEO stated that going forward the company will flesh out the numbers on the deals signed to date.
Just using the Endorsements from the two Medical Bodies that have agreed to promote the Trellus App covers the 3,000,000 sufferrers of Irittable Bowel Disease in the U.S.
If only 5% of sufferers use the app that's 150,000 patients and the company break even is 7,000.
The app has already shown that users are significantly less likely to require serious medical intervention of steroids, opioids and surgery with users reporting significant improvements in their mental well being and lifestyle.
This doesnt include the new IBS variant of the app which is due to launch and other world markets.
2 of America's biggest health cover providers are looking at it as their costs for sufferers of poorlifestyle management and non adherence to medical treatments cost them Billions per year.
3 contracts signed in New York state already, assuming even distribution of sufferers per state its circa 60,000 patients per state but New York will be higher than Nebraska say, could they already be at 7,000 patients signed up with the New York contracts?
Even better then! Great stuff!